tiprankstipranks
Phio Pharmaceuticals (PHIO)
NASDAQ:PHIO
US Market
PHIO
Phio Pharmaceuticals
RESEARCH TOOLSreports

Phio Pharmaceuticals (PHIO) Stock News & Sentiment

648 Followers
Phio Pharmaceuticals Establishes New At-the-Market Equity Program
Premium
Company Announcements
Phio Pharmaceuticals Establishes New At-the-Market Equity Program
5d ago
8K
PHIO
Phio Pharmaceuticals Secures cGMP Manufacturing for Clinical Supply
Premium
Company Announcements
Phio Pharmaceuticals Secures cGMP Manufacturing for Clinical Supply
14d ago
8K
PHIO
Buy Rating on PHIO: Strong Early PH-762 Clinical Data and Solid Cash Runway Support Upside Potential
Premium
Ratings
Buy Rating on PHIO: Strong Early PH-762 Clinical Data and Solid Cash Runway Support Upside Potential
1M ago
PHIO
Phio Pharmaceuticals Boosts CEO Severance and Incentive Compensation
Premium
Company Announcements
Phio Pharmaceuticals Boosts CEO Severance and Incentive Compensation
2M ago
8K
PHIO
Phio Pharmaceuticals Reports Positive PH-762 Phase 1b Safety Results
Premium
Company Announcements
Phio Pharmaceuticals Reports Positive PH-762 Phase 1b Safety Results
2M ago
8K
PHIO
Buy Rating on Phio Pharmaceuticals: Early PH-762 Efficacy, Clean Safety Profile, and Solid Cash Runway Support Favorable Risk–Reward
Premium
Ratings
Buy Rating on Phio Pharmaceuticals: Early PH-762 Efficacy, Clean Safety Profile, and Solid Cash Runway Support Favorable Risk–Reward
3M ago
PHIO
Phio Reports Positive Phase 1b PH-762 Skin Cancer Data
Premium
Company Announcements
Phio Reports Positive Phase 1b PH-762 Skin Cancer Data
3M ago
8K
PHIO
More PHIO News >

PHIO News on the Web

Phio Pharmaceuticals Establishes New At-the-Market Equity Program
TipRanks News
Neutral
Phio Pharmaceuticals Secures cGMP Manufacturing for Clinical Supply
TipRanks News
Neutral
Buy Rating on PHIO: Strong Early PH-762 Clinical Data and Solid Cash Runway Support Upside Potential
TipRanks News
Bullish
PHIO’s PH-762 Posts Strong Safety Results and High Response Rate in Skin Cancer Trial—What Does This Mean for the Future?
Market Chameleon
Neutral
Analysts Offer Insights on Healthcare Companies: Phio Pharmaceuticals (PHIO) and Cabaletta Bio (CABA)
TipRanks News
Bullish
Phio Pharmaceuticals Reports Positive PH-762 Phase 1b Safety Results
TipRanks News
Neutral
PHIO Phase 1b Trial: Positive Safety Findings and 85% Response Rate Highlight Potential of PH-762 in Skin Cancer
Market Chameleon
Bullish
Phio To Commence A Toxicology Study For PH-762; Initiatives Underway For A Viable Product In 2026
rttnews
Neutral

News Score - Last 7 Days

Neutral
PHIO
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average69%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is PHIO’s Media Buzz Sentiment?
1 articles about PHIO were published this week. In an average week, 1 articles are published.
    What is PHIO’s weekly average amount of articles?
    In an average week, 1 articles about PHIO are published.
      What is PHIO’s News Sentiment?
      50% of articles about PHIO were positive this week, compared to its sector average of 69%.
        Healthcare Stocks that are Trending in the News
        AORTArtivion
        TXTMProText Mobility
        STAAStaar Surgical
        ALLOAllogene Therapeutics
        IVVDInvivyd
        Showing the stocks with the most bullish news sentiment over the past week